New York Life Investment Management LLC Purchases 115 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

New York Life Investment Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,721 shares of the biotechnology company’s stock after purchasing an additional 115 shares during the period. New York Life Investment Management LLC’s holdings in Axon Enterprise were worth $5,777,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Public Sector Pension Investment Board lifted its holdings in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares in the last quarter. CIBC Asset Management Inc lifted its holdings in shares of Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares in the last quarter. Axxcess Wealth Management LLC bought a new stake in shares of Axon Enterprise in the third quarter valued at about $814,000. Soros Capital Management LLC bought a new stake in shares of Axon Enterprise in the third quarter valued at about $630,000. Finally, Friedenthal Financial raised its holdings in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after acquiring an additional 1,231 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on AXON. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a report on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Activity

In other news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at $84,168,016.18. The trade was a 1.76 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $528.45 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The business’s 50 day moving average price is $609.55 and its two-hundred day moving average price is $523.20. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $40.30 billion, a PE ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.